期刊文献+

IL-22和IL-17 mRNA在慢性HBV感染者PBMCs中的表达及其意义 被引量:4

IL-22 and IL-17 mRNA expression in PBMCs from patients with chronic hepatitis B virus infection
下载PDF
导出
摘要 目的:探讨慢性HBV感染者外周血单个核细胞IL-22和IL-17 mRNA表达及其对病情转归的影响.方法:以慢性乙型肝炎中度患者33例、重度患者21例、重型肝炎患者16例、乙型肝炎肝硬化患者16例和健康对照10例为研究对象,采用RT-PCR方法检测患者外周血单个核细胞IL-22和IL-17 mRNA的表达.结果:CHB中度、CHB重度和肝硬化患者IL-22表达水平无统计学意义,但均高于健康对照组,差异有统计学意义(P=0.000);而重型肝炎患者IL-22表达水平低于该3组患者,高于健康对照组,但差异无统计学意义(P=0.064).各组IL-17表达水平相似但均高于健康对照组,差异有统计学意义(P=0.000);重型肝炎患者IL-17表达水平均低于其他3组患者,与CHB中度患者比较差异有统计学意义(P=0.014),与CHB重度和肝硬化患者比较差异无统计学意义(P=0.172,0.968).结论:IL-22的下调不利于肝细胞损伤后的修复,IL-22分泌的增加对减轻肝组织的损伤特别是重型肝炎的恢复可能是有意义的.慢性HBV感染患者IL-17均明显升高,提示其可能参与慢性HBV感染肝组织炎症的发生,且对慢性肝病纤维化起一定作用. AIM: To detect the expression of IL-22 and IL-17 mRNAs in peripheral blood mononuclear cells (PBMCs) from patients with chronic hepatitis B (CHB) infection and to analyze their significance in the pathogenesis of CHB. METHODS: Thirty-three patients with moderate CHB, 21 patients with severe CHB, 16 patients with liver failure, and 16 cirrhotic patients were enrolled in the study. Ten healthy volunteers were used as controls. RT-PCR method was used to detect the expression of IL-22 and IL-17 mRNAs in PBMCs from these subjects. RESULTS: IL-22 expression in PBMCs from pat- ients with moderate CHB, severe CHB, or cir-rhosis was comparable, but all was higher than that from controls (P = 0.000). IL-22 expression in PBMCs from patients with liver failure was significantly lower than that from other three groups of patients (P = 0.000). IL-17 expression in PBMCs from four groups of patients was higher than that from controls (P=0.000). IL-17 expression in PBMCs from patients with liver failure was slightly lower than that from other three groups of patients, although no statistical difference was found. CONCLUSION: Down-regulation of IL-22 is unfavorable to repair of hepatic cells after liver injury. Up-regulation of IL-22 expression may be important in alleviating liver damage. IL-17 levels in patients infected with HBV are in- creased significantly. IL-17 may participate in the inflammatory process in chronic HBV infec- tion and play an important role in development of liver fibrosis.
出处 《世界华人消化杂志》 CAS 北大核心 2012年第34期3380-3384,共5页 World Chinese Journal of Digestology
关键词 慢性HBV感染 免疫 白介素-22 白介素-17 Hepatitis B Immunity IL-22 IL-17
  • 相关文献

参考文献8

二级参考文献55

  • 1Zhang, Yu,Zhou, Jian-Hua,Yin, Xiao-Ling,Wang, Feng-Yu.Treatment of hepatitis B virus-associated glomerulonephritis:A meta-analysis[J].World Journal of Gastroenterology,2010,16(6):770-777. 被引量:38
  • 2成彩联,娄探奇,郑振达,石成钢,刘迅.霉酚酸酯联合激素及拉米夫定治疗乙肝相关性肾炎的观察[J].中国实用内科杂志,2005,25(12):1083-1085. 被引量:22
  • 3周光宇,苏雪松,李德天,王艳秋,孙广萍.霉酚酸酯治疗乙型肝炎病毒相关性肾炎的临床观察[J].中国实用内科杂志,2007,27(14):1130-1132. 被引量:12
  • 4Infante-Duarte C, Horton HF, Byrne MC, et al. Microbial lipopeptides induce the production of IL-17 in Th cells. J lmmunol, 2000, 165:6107-6115.
  • 5Langrish CL, Chen Y, Blumensehein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med, 2005, 201:233-240.
  • 6Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat lmmunol, 2005, 6:1133-1141.
  • 7Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effeetor TH17 and regulatory T cells. Nature, 2006, 441:235-238.
  • 8Beckebaum S, Cicinnati VR, Zhang X, et al. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro : mechanisms for viral immune escape. Immunology, 2003, 109:487-495.
  • 9Freeman AJ, Marinos G, Ffrench RA, et al. Immunopathogenesis of hepatitis C virus infection, Immunol Cell Biol, 2001, 79:515-536.
  • 10Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity, 2004, 21:467-476.

共引文献14042

同被引文献96

  • 1Akdis M, Palomares O, van de Veen W, van Splunt- er M, Akdis CA. TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflamma- tion versus protection. J Allergy Clin Immunol 2012; 129: 1438-1449; 1438-1449; [PMID: 22657405 DOI: 10.1016/j.jaci.2012.05.003].
  • 2Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)I and T(H)2 cells. Nat Immunol 2009; 10:864-871 [PMID: 19578368 DOI: 10.1038/ni.1770].
  • 3Eyerich S, Eyerich K, Pennino D, Carbone T, Na- sorri F, Pallotta S, Cianfarani F, Odorisio T, Traidl- Hoffmann C, Behrendt H, Durham SR, Schmidt- Weber CB, Cavani A. Th22 cells represent a distinct human T cell subset involved in epidermal immuni- ty and remodeling. J Clin Invest 2009; 119:3573-3585 [PMID: 19920355 DOI: 10.1172/JCI40202].
  • 4Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009; 10:857-863 [PMID: 19578369].
  • 5Dumoutier L, Louahed J, Renauld JC. Cloning and characterization of IL-10-related T cell-derived in- ducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 2000; 164:1814-1819 [PMID: 10657629].
  • 6Zhang N, Pan HF, Ye DQ. Th22 in inflammatory and autoimmune disease: prospects for therapeu- tic intervention. Mol Cell Biochem 2011; 353:41-46 [PMID: 21384158 DOI: 10.1007/s11010-011-0772-y].
  • 7Nograles KE, Zaba LC, Shemer A, Fuentes-Duculan J, Cardinale I, Kikuchi T, Ramon M, Bergman R, Krueger JG, Guttman-Yassky E. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 2009; 123:1244-1252.e2 [PMID: 19439349 DOI: 10.1016/j.jaci.2009.03.041].
  • 8Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, Doherty JM, Mills JC, Colonna M. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009; 457:722-725 [PMID: 18978771 DOI: 10.1038/na- ture07537].
  • 9Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008; 14:282-289 [PMID: 18264109 DOI: 10.1038/nm1720].
  • 10Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, Wood WI, Goddard AD, Gurney AL. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF24 and IL-22R. J Biol Chem 2000; 275: 31335-31339 [PMID: 10875937 DOI: 10.1074/jbc. M005304200].

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部